Oxford University believes that in September it may have the vaccine against Covid-19. A research group has achieved effective results in monkeys and by the end of May will be testing the drug on 6,000 people.
Oxford's leadership in the race to find a vaccine against the Covid-19 pandemic is explained by the fact that last year a team of researchers from the Edward Jenner Institute for Vaccine Research managed to demonstrate that in the case of other coronaviruses, the inoculations were harmless to humans.
Now, scientists will go ahead with tests on six thousand people to verify the effectiveness of the vaccine, which has already been tested on monkeys and with promising results.
In March, the drug was administered to rhesus monkeys, "the most similar to humans," Vincent Munster, responsible for the study, told The New York Times.
Of the group of primates, widely exposed to the new coronavirus, the six who received a single dose of the vaccine remained healthy for more than 28 days and those who did not receive any treatment became ill.
It remains to be seen whether efficacy is verified in humans or not. In case they manage to prove that it works, they believe that the urgent approval of this drug by the regulatory authorities can put on the market the first million doses of vaccines against Covid-19 already in September.
The Jenner Institute’s research focuses on changing the virus’s genetic code to neutralize its effects by injecting a harmless compound that forces the immune system to fight and kill the target virus, in this case Sars-Cov-2, the new coronavirus, providing protection to the body.
The first phase of the clinical trial in humans has already started with 1,100 volunteers and, by the end of May, six thousand will be vaccinated to verify the efficacy and also the safety of the drug.
The party will only arrive if the results show that more than a dozen participants who received placebo (a substance without effects) in the trial became sick with Covid-19 compared to only one or two who received the real vaccine.